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Research on large shared medical datasets and data-driven research are gaining fast 
momentum and provide major opportunities for improving health systems as well as 
individual care. Such open data can shed light on the causes of disease and effects of 
treatment, including adverse reactions side-effects of treatments, while also facilitating 
analyses tailored to an individual’s characteristics, known as personalized or “stratified 
medicine.” Developments, such as crowdsourcing, participatory surveillance, and indi-
viduals pledging to become “data donors” and the “quantified self” movement (where cit-
izens share data through mobile device-connected technologies), have great potential to 
contribute to our knowledge of disease, improving diagnostics, and delivery of healthcar e 
and treatment. There is not only a great potential but also major concerns over privacy, 
confidentiality, and control of data about individuals once it is shared. Issues, such as user 
trust, data privacy, transparency over the control of data ownership, and the implications 
of data analytics for personal privacy with potentially intrusive inferences, are becoming 
increasingly scrutinized at national and international levels. This can be seen in the recent 
backlash over the proposed implementation of care.data, which enables individuals’
NHS data to be linked, retained, and shared for other uses, such as research and, more 
controversially, with businesses for commercial exploitation. By way of contrast, through 
increasing popularity of social media, GPS-enabled mobile apps and tracking/wearable 
devices, the IT industry and MedTech giants are pursuing new projects without clear 
public and policy discussion about ownership and responsibility for user-generated data. 
In the absence of transparent regulation, this paper addresses the opportunities of Big 
Data in healthcare together with issues of responsibility and accountability. It also aims to 
pave the way for public policy to support a balanced agenda that safeguards personal 
information while enabling the use of data to improve public health.
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iNtrODUctiON
The recent emergence of Big Data in healthcare [including large 
linked data from electronic patient records (EPR) as well as 
streams of real-time geo-located health data collected by personal 
wearable devices, etc.] and the open data (movement enabling 
sharing datasets) are creating new challenges around ownership 
of personal data while opening new research opportunities and 
drives for commercial exploitation (1). A balance must be struck 
between an individual’s desire for privacy and their desire for 
good evidence to drive healthcare, which may sometimes be in 
conflict. Opportunities for research on EPR and public health 
medical datasets have already demonstrated impressive results 
in generating new evidence (2); however, new computer science 
approaches analyzing real-time Big Data streams generated by 
social media and increasingly popular tracking/wearable devices 
have re-charted the data ownership landscape. And dramatically 
accelerated computing research activities into pilots demonstrat-
ing improving personal health outcomes and disease management 
through knowledge discovery and personalized medicine (3, 4) to 
provide signals for early warning for outbreaks and pandemics (5, 
6) as well as to track citizens response (7).
With the increasing use of mobile and wearable devices (8), new 
opportunities were created for personalized health (tailored care 
to the needs of an individual) (9), crowdsourcing, participatory 
surveillance, and movement of individuals pledging to became 
“data donors” and the “quantified self ” initiative1 (where citizens 
share data through mobile device-connected technologies). 
These initiatives created large volumes of data with considerable 
potential for research through open data initiatives. However, 
user privacy and ownership of user-generated data remain an 
under-explored territory from policy and regulatory perspectives 
while becoming a booming business for social media industry 
and MedTech manufactures (10).
Therefore, in the absence of transparent data ownership 
regulation, two strikingly disparate approaches emerged for data 
ownership, usage, and responsibility over sharing and account-
ability: first, government-regulated clinical and research medical 
data (including individual and population data gathered by non-
government organizations in high- and low-income settings) 
and, second, private user-generated health data collected from 
social media, apps, online searches and wearable devices.
First, poor government communication, unclear agendas, and 
lack of transparency over the control and ownership of medical 
data are increasingly scrutinized at national and international 
levels. For example, in the UK, those hoping to deliver improved 
healthcare on the back of better access to individual data have 
failed to gain citizens’ trust. This was seen in the backlash over 
the proposed implementation of the care.data initiative in the UK 
(11) intended to enable large NHS individual data sharing with 
researchers and, controversially, with businesses which resulted 
in a failure of the initiative (12).
Second, some citizens seem little concerned over their much 
more accurate and potentially private user-generated health data 
1http://quantifiedself.com/ 
being directly collected by IT and social media companies and 
MedTech manufactures through tracking/wearable devices and 
social media with commonly no opt-out options, potentially sub-
ject to personal intrusion using data analytics driven marketing 
and unregulated sharing and use (13).
However, this observation raises interesting questions: what 
are the motivations of citizens who are at the intersection of 
these two groups and what is the size of this “contradicting” 
population? Could this behavior be explained by simply a 
lack of awareness of seamless data collection (13)? Or is the 
mater more complex: there might be citizens feeling that their 
explicit consent is required for data sharing in the former group 
(where the data are extracted from clinical records to be shared), 
while they agreed to sharing with IT and MedTech industry 
in the second group (where the user-generated content could 
be considered donated by accepting terms and conditions). 
Better understanding of citizens’ motivations requires further 
research, especially as many terms of condition often provide 
no opt-out options. Nevertheless, perhaps more important 
than ownership and consent for sharing data, is the question 
of: by whom and for what purposes are shared citizens data used 
and how could decisions be effectively controlled by citizens 
themselves?
BeNeFits OF OPeNiNG UP HeALtH DAtA 
FOr reseArcH
At the clinical/population and research data level, opening 
up medical data, sharing and linking large healthcare datasets 
enables semantically to relate and enrich data on symptoms, 
diseases, diagnosis, treatments, and prescriptions offering the 
potential for improvements in care for individuals and popula-
tions as well more efficient semantic access to the evidence base 
(14, 15). Linking datasets further enhances this potential, help-
ing to produce new evidence, discovery of unknown symptoms 
and personal treatments, and better understanding of health 
outcomes and healthcare delivery challenges. This is invalu-
able for policymakers (e.g., geographical analysis of antibiotics 
prescription rates) as well as enabling more efficient ways of 
working for healthcare practitioners (e.g., automated repeated 
prescriptions have been reducing GP consultation time) (16). 
However, while many service providers and users are happy to 
see their data shared for reasons of altruism, there is recogni-
tion that there may also have to be more immediate benefits for 
individuals and practitioners, and clearer communication of 
those benefits (17).
From citizens’ perspective benefits come with, for example, 
better understanding of specific diseases, improvements in care 
for long-term conditions, and opportunities for home care using 
remote and telehealth technologies enabled by easier access to 
information. Though while record systems are being opened up 
to individuals, beyond specialist areas of care there has not been 
enormous uptake or clear demonstration of the benefits (18).
There are also benefits from sharing information on 
social inequities and population health at all levels: globally 
(for example, comparing low- and high-income countries), 
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nationally, and locally (e.g., class inequity). The sharing of large 
population level data helps researchers to accurately describe 
these inequities and highlight problematic areas, specific 
target groups, and geographical and regional challenges to be 
addressed through new sets of evidence-based dedicated health 
interventions.
The Internet of Things (IoT) is part of the era of the “Internet 
of Everything”  –  computers, data, processes, sensors, people, 
wearable, and tracking medical devices (soon 50 billions of smart 
objects worldwide) are being connected to the Internet and use 
distributed cloud-based data storage infrastructures (19). These 
technological advances created an unprecedented level of per-
sonal data sharing from wearable medical devices, social media, 
and personal fitness tracking, to loyalty cards recording our shop-
ping habits. New algorithms for Big Data mining and analytics 
investigating streams of real-time personalized time/geo-located 
data sources provide new opportunities for personalized health 
advice, monitoring, and treatment of specific conditions as well 
as increasing wellbeing (20).
Finally, there are other large datasets potentially benefiting 
from research: government population level epidemiological 
datasets collected through surveillance systems. There are suc-
cessful moves in this direction, such as the UK national influenza 
surveillance program [Royal College of General Practitioners 
Research and Surveillance Centre (21)], however, the ideal 
case for research exploitation of population level data with no 
privacy concerns would be enabling access to datasets in machine 
readable format, championed by the Linked Data initiative (22). 
At international level, sharing even historical population level 
data remains a challenge. While disease risk notifications are 
legally defined by WHO at international level (International 
Health Regulations, IHR) and ECDC (EC Decision 2008/426/
EC) countries remain in control of the datasets collected by their 
public health surveillance services. While these dataset could 
be invaluable for scientific research as well as epidemic intel-
ligence and early-warning services, national legal frameworks 
and operational procedures limit sharing even between public 
health agencies. Increasingly challenged by open data initiatives 
in the public health domain, real-time data sharing could enable 
faster and better coordinated response during emergencies while 
opening new frontiers for data-driven interdisciplinary research 
in public health (23).
cHALLeNGes OF DAtA sHAriNG FOr 
reseArcH
There are a number of challenges and potentially negative 
consequences to be addressed by new policies and regulations, 
through technical achievements and evidence-based healthcare 
interventions.
In addition to individual privacy discussed in detail in the 
next section, the high noise of large datasets is a major challenge 
requiring new analytics methods. Current methods still lack the 
level of robustness needed, resulting in misinterpretations and 
generation of false positive signals. Data security for large distrib-
uted infrastructures also requires rethinking our understanding 
of privacy and control and designing novel, secure computer 
system ecosystems. Data control is key to the success of comput-
ing approaches that underpin the digital economy (24).
Increased health interventions without clinically proven out-
comes become a risk when research outcomes from large datasets 
are used to identify user-served individuals and disease areas for 
interventions ahead of the scientific evidence (for example, cervi-
cal screening prophylaxis occurring annually in the US).
Traditionally valued GP-individual relationships, based on the 
notion of family physicians was changed due to more frequent 
moves of citizens and new pressures on GPs to collect more “qual-
ity data” with technologies – enabling not only care improvement 
but also quality monitoring and GP remuneration. For multiple 
reasons, healthcare sectors in the UK and Europe are witnessing 
changes in delivery and continuity of care. Once a social contract 
between healthcare services and individuals it is now a relation-
ship that takes profit into consideration.
iNteGrAtiNG DAtA tO DeLiver 
HeALtH-cAre BeNeFits
Healthcare research on Big Data not only creates numerous 
opportunities but also brings new challenges – in particular, large 
storage, real-time analytics, and secure integration of distributed 
datasets.
Emerging data federation technologies enable new data 
sharing models across distributed data sources of information 
(internal or cloud-based sources). Data virtualization technolo-
gies (25) make it possible to run real-time analytics over high 
volume of distributed data while enforcing a robust security 
policy (data governance). Data do not need to be moved into a 
single location (as in the traditional approach) but remain in a 
repository while thousands of parallel queries can access them. 
This approach has been used successfully by pharmaceutical 
companies to accelerate their research projects and bring agil-
ity to the data scientists’ use of diverse data sources [such as at 
Pfizer (26)].
Encouraging examples are emerging from low- and middle-
income settings. The INDEPTH network of autonomous popu-
lation health and demographic surveillance sites throughout 
Africa and Asia launched its iShare initiative (www.indepth-
ishare.org) in 2009, whereby several sites share almost 12.5 
million person years of observational data from settings where 
little other population health data exist. Each of the participating 
sites is an independent organization. Yet through coordination 
by the southern-led INDPETH network, it has been possible to 
agree on processes, core minimum micro-dataset specifications, 
and conditions of use that overcome individual institutional 
constraints to make the most of available data to improve 
understandings of health and delivery of services. Leadership 
and finance are crucial to such initiatives and need to reflect 
local technical capacity and explicit strategies to recognize and 
respond to differing individual citizen, data-producer, and data-
user needs.
In addition, harnessing the potential of real-time geo-located 
“unconventional” data sources, such as social media streams, 
loyalty cards, GPS-enabled mobile apps, and search queries 
adds another complex layer of privacy challenges. Never has 
February 2016 | Volume 4 | Article 74
Kostkova et al. Who Owns the Data?
Frontiers in Public Health | www.frontiersin.org
so much data about so many people been held by so few with 
little policy and legal oversight and regulation, such as the case 
of IT companies and mobile data-driven start-ups (27). These 
data sources need to be made available for research, regardless of 
where the data comes from and by whom it has been collected, 
or its potential will never be realized for the individual user nor 
for the public good, while respecting valued private information 
about citizens, e.g., their current location (28).
BALANciNG Access tO DAtA WitH 
iNDiviDUAL PrivAcY
Individual’s attitudes towards healthcare services have undergone 
a major social and cultural shift over the last two decades, bring-
ing new insights and attitudes to individuals’ privacy.
As discussed above, there are two sharply distinct approaches: 
traditional government healthcare and non-government research 
datasets, and novel user-generated personalized data held pre-
dominantly by industries.
Traditionally, an individual was a part of a healthcare system 
through an accepted social contract, implying rights as well as 
responsibilities for consent, protection, and privacy. In the new 
context of “consumer” healthcare services, research needs to 
renegotiate rights to use of data. This involves trust as well as 
technical security measures (29). Without this the potentially 
beneficial evidence for individuals and for populations as a whole 
would not be unlocked.
Attitudes against sharing medical information can stem from 
confusing messages and lack of controls in the past, as well as fear 
of the data being shared with third parties invading privacy and 
enabling personal data exploitation against individual’s interests, 
for example, with an insurance provider. Rather than an abstract 
notion of how data sharing may benefit person-kind, citizens’ 
engagement needs to be specific and honest about the risks and 
benefits of data sharing. While at the policy level, steps toward 
increasing transparency of data governance and de-identification 
techniques preserving meaningful usability of data for research 
are the key challenges (rather than anonymization with might 
make the data meaningless as a result). Transparency and open 
dialog with citizens are paramount for regaining public trust and 
setting cornerstones for a balanced agenda.
A striking contrast is provided by person physiological and 
medical data which is collected in vast quantities through social 
medial, wearable and tracking devices, MedTech and geo-located 
mobile apps (30). While there are differences in the legal environ-
ment in Europe and the US, without much awareness and concerns 
by users and in absence of policy debate, personal data are subject 
to industry-defined terms of conditions often with no opt-out 
clauses allowing use for personalized online/mobile marketing, 
internal research, and sale to third parties that could be in breach 
of the requirements of the Data Protection Act fair processing [as 
the recent example of OKCupid experiment and Uber provision 
of transport data to the Boston municipality (31)]. Much needed 
oversight, international government regulation and restoration of 
user control of personal data are essential to rebalance the current 
situation.
DeveLOPiNG resPONsiBLY BiG DAtA 
AND OPeN DAtA FOr HeALtH
Public and business engagement in data regulation debates is 
essential for delivering better health outcomes. Risk-adverse 
regulatory authorities should be challenged by citizens and the 
research communities to engage in setting a balanced agenda that 
would benefit citizens and research communities.
•	 Public and citizen engagement: wider public awareness campaigns 
about the benefits and risks of sharing data could have positive 
effects but should be based on evidence and empirical methods 
while providing “success stories.” This will inevitably be a long-
term process of developing an ongoing dialog with public, private 
sector and policymakers while increasing citizens trust in the gov-
ernment and understanding of data usage for research for public 
good. True media engagement reinforcing this dialog across the 
media spectrum rather than reversing the process through sensa-
tional coverage might be very challenging to establish.
•	 Clarity and transparency: data transparency and terms of use 
require a shared goal setting the core principles and establish-
ing a regulation process that is fit for purpose. Transparency 
and clarity implies regulations and enforcement and also 
needs to be extended to public understanding of benefits and 
risks of data sharing (as defined by the Fundamental require-
ment for DPA Principle 1), strong disclosure, and notification 
mechanism informing public about potential violations. While 
there is little to disagree with the practical implementation of 
reinforcement of these principles is a different matter.
•	 New regulatory framework: a radical shift in the direction of 
regulation of data usage by industry should be developed. For 
Big Data, businesses giving control back to users generating 
the data (who could decide to sell the data back to the IT 
companies, for example) would require a very radical shift in 
existing business models  –  with the increasing closeness of 
big businesses to governments, perhaps, the biggest challenge 
among these to address at the moment.
•	 New data structures and Big Data analytics: common 
interoperability standards and new information sharing 
federal architectures for better Big Data storage and real-time 
analytics are required to deliver solutions that benefit indi-
viduals, practitioners, and healthcare professionals at every 
level. Transparently regulated third-party run data registries 
might provide an answer to the need for safe personal data 
repositories while offering access to data to authorized parties 
in machine readable formats (over an API, for example). 
Engagement of computer scientists and strong support for 
interdisciplinary collaborations should be championed.
•	 Training and education: citizens and healthcare professionals 
need to be better equipped with computing and ethical skills to 
enable future workforces to take full advantage of the digital rev-
olution. Creating centers of excellence training future research-
ers and medical professionals in expertise in Big Data and open 
data – creating an essential interdisciplinary workforce should 
be a priority. Furthermore, training should also enable citizens 
and local communities in national and international settings to 
address local problems and draw from community needs.
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cONcLUsiON AND KeY 
recOMMeNDAtiONs
The potential of opening healthcare data and sharing big datasets 
is enormous – but the challenges and barriers to achieve this goal 
are enormous. As transparent access to Big Data is the key chal-
lenge for healthcare research on clinical and population research 
datasets, policymakers, and scientific and business communities 
should embrace the underlying challenges of a political and legal 
nature. Finding novel approaches to satisfy business interests 
and actively engage the public are essential for opening avenues 
to a balanced equilibrium: transparent data access for research 
needs and large-scale integrations preserving individual privacy. 
Technological advances on data sharing and transparency need 
to be driven by interdisciplinary research and translated into 
training of the future workforce.
Ultimately, healthcare policymakers at international level need 
to develop a shared policy and regulatory framework supporting 
a balanced agenda that safeguards personal information, limits 
business exploitations, and gives out a clear message to the public 
while enabling the use of data for research and commercial use. 
This would potentially improve the health of millions.
In lights of the risk-adverse pro-business policy making 
attitudes in this domain, it is the golden opportunity and pro-
fessional responsibility of the research community to challenge 
policymakers and regulatory bodies authorities and actively lead 
on the complex multi-stakeholder processes of establishing this 
new agenda.
AUtHOr cONtriBUtiONs
The high profile open data event involved 13 invited panelists 
and was cobadged with i-sense, the EPSRC IRC in Early 
Warning Sensing Systems for Infectious Diseases. Chaired by 
Sir John Tooke, the UCL Vice-Provost (Health), the 2 hours 
debate covered a broad range of themes representing views 
from the key stakeholders, including government, policymakers, 
NHS, academia, and industry. The initial proposal was to address 
the following five questions, but due to time constraints, only the 
first four were discussed. This paper was written up by Dr. Patty 
Kostkova with input provided by the panelists.
Q1. What are the benefits of opening up clinical data for health 
research?
Q2. How can data from different sources (public and private, 
including non-traditional sources) be merged to deliver 
health-care benefits?
Q3. How do we balance access to data with individual privacy?
Q4. What policy changes are needed to responsibly develop Big 
Data for health?
Q5. What are the lessons learned from care.data?
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